| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/06/2008 | EP1952826A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 08/06/2008 | EP1744789B1 X-ray and/or uv activatable particles, their preparation and their therapeutic or diagnostic uses |
| 08/06/2008 | EP1409024B1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 08/06/2008 | EP1015884B1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 08/05/2008 | US7408050 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 08/05/2008 | US7408046 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders |
| 08/05/2008 | US7407673 Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof |
| 08/05/2008 | US7407645 Contast agents;magn |
| 08/05/2008 | US7407644 Covalently binding an antioxidant such as ascorbic acid, p-aminobenzoic acid, cysteine, monothioglycerol, or gentisic acid with ligand: Oxa-PnAO, N,N-dimethyl Gly-Ser-Cys-Gly, N,N-dimethyl-Gly-t-butylGly-Cys-Gly, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; optional targeting molecule |
| 07/31/2008 | WO2008091195A1 Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives |
| 07/31/2008 | WO2008090731A1 Method for producing 2-nitroimidazole derivative |
| 07/31/2008 | WO2008089567A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089566A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008054535A3 Novel influenza m2 vaccines |
| 07/31/2008 | WO2008027995A3 Radio-labeled materials and methods of making and using the same |
| 07/31/2008 | WO2007148083A3 Stabilisation of radiopharmaceutical precursors |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182283 Inhibitors of human plasmin derived from the kunitz domains |
| 07/31/2008 | US20080181848 Method to detect dopamine receptors in the functional d2high state |
| 07/31/2008 | US20080181847 kit of imaging probe, e.g.substituted triphenyl phosphine-paramagnetic metal(tetraazacyclododecane) complex; and targeting probe comprises the at least one azide group |
| 07/31/2008 | CA2676413A1 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 07/31/2008 | CA2676214A1 Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives |
| 07/31/2008 | CA2675293A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2675292A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2674897A1 Cancerous disease modifying antibodies |
| 07/30/2008 | EP1948693A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 07/30/2008 | EP1553986B1 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic |
| 07/30/2008 | EP0912738B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 07/30/2008 | CN101233117A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 07/30/2008 | CN100406065C Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 07/29/2008 | US7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 07/29/2008 | US7404969 One or more short interfering RNA, 3-dimethylamino-2-(cholest-5-en-3-beta-oxybutan-4-oxy)-1-(cis,cis-9,12-octadecadienoxy) propane, distearoyl phosphatidylcholine, cholesterol, and 1-[8'-(1,2-Dimyristoyl-3-propanoxy)-carboxamido-3',6'-dioxaoctanyl]carbamoyl-omega-methyl-polyethylene glycol; transfection |
| 07/29/2008 | US7404963 Flagellin-based adjuvants and vaccines |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404945 Method of evaluating pharmacological effects of medicine |
| 07/29/2008 | CA2383600C Method for determining viability of a myocardial segment |
| 07/29/2008 | CA2307002C Antitumour uridine analogues |
| 07/29/2008 | CA2291685C Pharmaceutical product for the detection of helicobacter pylori-induced gastrointestinal disorder |
| 07/29/2008 | CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/24/2008 | WO2008088594A2 Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species |
| 07/24/2008 | WO2008088561A1 Device and method for labeling and measuring the radiochemical purity of radio-drugs |
| 07/24/2008 | WO2008022319A3 Catalytic radiofluorination |
| 07/24/2008 | WO2006116798A9 A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | US20080175788 Analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG |
| 07/23/2008 | EP1946797A2 Radioactive ion |
| 07/23/2008 | EP1946796A2 Radioactive ion |
| 07/23/2008 | EP1946775A2 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 07/23/2008 | EP1945622A1 Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins |
| 07/23/2008 | EP1945273A1 Treatment and prevention of adverse liver conditions using gallium |
| 07/23/2008 | EP1945272A1 Method of scintigraphy |
| 07/23/2008 | EP1945159A2 Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
| 07/23/2008 | CN100405511C Water-base magnetic liquid and producing method thereof |
| 07/23/2008 | CN100404075C Preparation method of interpose internal radiation anti tumour series medicine |
| 07/22/2008 | US7402401 Determining whether ST receptor protein or mRNA encoding it is present in lymph node; polymerase chain reaction and binding assay |
| 07/22/2008 | US7402385 Bind to cellular component released by a dying tumor cell; imaging melanin-containing melanomas; radioimmunotherapy |
| 07/22/2008 | CA2244205C Methods and compositions for enhancing the bioadhesive properties of polymers |
| 07/22/2008 | CA2222544C Site specific binding system, imaging compositions and methods |
| 07/22/2008 | CA2173324C Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 07/17/2008 | WO2008085266A2 Radioimmunotherapy and imaging of tumor cells that express viral antigens |
| 07/17/2008 | WO2008085216A1 Therapeutic hpph dosage for pdt |
| 07/17/2008 | WO2008059426A3 A system for determining a distribution of radioactive agents in a subject |
| 07/17/2008 | WO2008052187A3 Antibodies and immunoconjugates and uses therefor |
| 07/17/2008 | WO2007137121A3 Human oct-2 variant peptide chains, nucleic acids, and methods |
| 07/17/2008 | US20080170993 Thymidine analogs for imaging |
| 07/17/2008 | US20080170992 such as Positron Emitting Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) for detecting angiogenesis in solid tumors; cyclic peptide based on 2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclopentadecane ring having carboxymethyl, guanidine and radionuclide-containing side chains |
| 07/17/2008 | US20080170991 Selectively targeted antimicrobial peptides and the use thereof |
| 07/17/2008 | US20080170990 During vasodilator-induced myocardial stress perfusion imaging, by administering a partial A2A adenosine receptor agonist such as CVT-3033, Regadenoson; diagnosing myocardial dysfunction |
| 07/17/2008 | US20080170989 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 07/17/2008 | US20080170988 Method of Preparing Nanoparticles of Alginate-Galactosyl-Polylsine |
| 07/16/2008 | EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 07/16/2008 | EP1944281A1 18F-labeled compounds, method for the preparation and use thereof |
| 07/16/2008 | EP1943350A2 Latent procytotoxins and uses thereof |
| 07/16/2008 | EP1942950A2 Biodegradable composite for internal local radiotherapy |
| 07/16/2008 | EP1942949A1 Method for the synthesis of pentapendant enantiomer-pure chelators and process for therapeutically active bio-conjugates preparation by a covalent binding of thereof |
| 07/16/2008 | EP1581812B1 Compositions and methods for diagnosing and treating colon cancers |
| 07/16/2008 | EP1485160B1 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 07/16/2008 | CN101222943A Radiolabelled nanoparticles |
| 07/16/2008 | CN101220026A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 07/16/2008 | CN101219226A Medicinal box of GSA for producing technetium-99m mark and method for producing the same |
| 07/16/2008 | CN101219225A Improved gastrin releasing peptide compounds |
| 07/16/2008 | CN100402512C Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 07/16/2008 | CN100402093C Medicine used in medical breath diagnosis |
| 07/15/2008 | US7399835 Cancerous disease modifying antibodies |
| 07/15/2008 | US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 07/15/2008 | US7399460 Cancer diagnosis; antitumor agents, radiotherapy |
| 07/15/2008 | CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition |
| 07/15/2008 | CA2302524C Stable radioiodine conjugates and methods for their synthesis |
| 07/15/2008 | CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/10/2008 | WO2008083313A2 Methods and systems for integrated radiopharmaceutical generation, preparation, transportation, and administration |
| 07/10/2008 | WO2008083056A2 Ligands for imaging cardiac innervation |
| 07/10/2008 | WO2008083054A2 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure |
| 07/10/2008 | WO2008082885A2 Transport molecules using reverse sequence hiv-tat polypeptides |
| 07/10/2008 | WO2008082695A2 Methods and agents for preparing 18f-radiolabeled fluorinating agents |
| 07/10/2008 | WO2008082545A2 Imaging using radioactive monocations in combination with a receptor binding ligand that stimulates the influx of cations |
| 07/10/2008 | WO2008081447A2 Compounds and methods for detection of cells |
| 07/10/2008 | WO2008060367A9 Human antibodies that bind cxcr4 and uses thereof |
| 07/10/2008 | US20080167544 Compositions And Methods For Locating An Internal Bleeding Site |